The in December 2025 published independent advisory report chaired by Peter Wennink translates the findings of the Draghi report on Europe’s future earning capacity to the Dutch context.

RegMed XB proudly contributes to ATMP XB, a €3.5 million Interreg-cofunded initiative led by Biovia, aimed at reinforcing the cross-border ecosystem for ATMPs in Flanders and the South of the Netherlands.

Eight initiatives funded through the Dutch National Growth Fund are joining forces to accelerate Life Sciences & Health innovation and sustainable economic growth, with a focus on societal impact in The Netherlands.